Micron Technology (NASDAQ:MU) was already a compelling buy as an undervalued AI enabler, but Citi’s upgraded outlook elevates it further. If the analyst’s projections materialize —… Read More »Could Micron’s Memory Boom Make It The New Oracle?
Electricity needs are increasing globally and triggering investors’ and industries’ interest in nuclear energy. Earlier this year, U.S. President Donald Trump signed a number of… Read More »Nuclear ETFs Up At Least 40% In The Past Year: More Gains In Store?
Ranking among the hottest initial public offerings, CoreWeave (NASDAQ:CRWV) — a cloud-computing company specializing in providing processing infrastructure to artificial intelligence developers and enterprises — once again… Read More »Hot Tech IPO CoreWeave Shoots Higher Thanks To AI Push
If you’re looking for safety and high yields, you may want to consider real estate investment trusts (REITs), especially those with yields above 10%. Making… Read More »5 REITs Paying Jaw-Dropping 10%+ Yields And Pay Cash Monthly
There’s no getting around it: September can be rocky. The stock market tends to display seasonal propensities, whereby certain months of the year have historically… Read More »September Swoon: Is A Big Sell-Off Imminent?
Nearly every financial article you read will tell you the same thing. Over the long haul, almost nothing beats the S&P 500. The index has… Read More »3 ETFs Trouncing The S&P 500’s Long-Term Gains
Where has the “smart money” been finding investment opportunities in this year’s market? To find out, we looked at the latest portfolios of some of… Read More »10 Stocks The Best Fund Managers Have Been Buying In 2025
The IPO market has been heating up lately as investors pile into riskier areas. Several high-profile private companies, particularly in the AI and crypto space,… Read More »Should You Invest In The Red-Hot IPO Market?
Sales are the lifeblood of any business, fueling the engine that drives profitability and, ultimately, stock price appreciation. Without consistent revenue from customers willing to… Read More »Profitable At Last: Will These 3 Tremendous High-Flyers Keep Soaring?
Novo Nordisk (NVO), the Danish pharmaceutical leader, has reclaimed its dominance in the GLP-1 market, driven by strategic agility and innovative breakthroughs. Known for its blockbuster… Read More »Novo Nordisk’s Epic Comeback: How It Reclaimed The GLP-1 Throne